Biotechnology for the diagnosis, treatment, and prevention of infectious diseases
DITAPREIN
Centro de Investigación Biomédica en Red de Enfermedades Infecciosas
Madrid, EspañaPublications in collaboration with researchers from Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (10)
2023
-
A call for the comprehensive diagnosis of viral hepatitis as a key step towards its elimination
Liver International
-
Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort
International Journal of Infectious Diseases, Vol. 137, pp. 134-143
-
Optimization of the molecular diagnosis of the acute hepatitis E virus infection
Microbial Biotechnology, Vol. 16, Núm. 6, pp. 1325-1332
-
Real-life validation of a sample pooling strategy for screening of hepatitis C
Clinical Microbiology and Infection, Vol. 29, Núm. 1, pp. 112.e1-112.e4
-
Transmitted Drug Resistance to Integrase-Based First-Line Human Immunodeficiency Virus Antiretroviral Regimens in Mediterranean Europe
Clinical Infectious Diseases, Vol. 76, Núm. 9, pp. 1628-1635
-
Transmitted drug resistance to antiretroviral drugs in Spain during the period 2019–2021
Journal of Medical Virology, Vol. 95, Núm. 12
2022
-
Epidemiological trends of HIV/HCV coinfection in Spain, 2015–2019
HIV Medicine, Vol. 23, Núm. 7, pp. 705-716
-
In vitro neutralizing activity of BNT162b2 mRNA-induced antibodies against full B.1.351 SARS-CoV-2 variant
Transboundary and Emerging Diseases, Vol. 69, Núm. 5, pp. 2649-2655
-
Outpatient Parenteral Antibiotic Treatment vs Hospitalization for Infective Endocarditis: Validation of the OPAT-GAMES Criteria
Open Forum Infectious Diseases, Vol. 9, Núm. 9
-
Ten steps to eliminating hepatitis C in hospitals
Nature Reviews Gastroenterology and Hepatology